We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Acute cardiac and hemodynamic effects of sildenafil on resistant hypertension.
- Authors
Quinaglia, Thiago; de Faria, Ana Paula C.; Fontana, Vanessa; Barbaro, Natália R.; Sabbatini, Andréa R.; Sertório, Jonas T.; Demacq, Caroline; Tanus-Santos, José E.; Moreno, Heitor
- Abstract
Purpose: Failure to control blood pressure (BP) despite the use of three or more drugs characterizes resistant hypertension (RHTN). Impaired endothelial function is associated with this condition and phosphodiesterase-5 inhibitors (PDE5i)—inhibiting cGMP breakdown—reduce BP in RHTN patients. We hypothesized that acute administration of PDE5i could ameliorate hemodynamic, endothelial parameters and left ventricular diastolic function (LVDF) in RHTN patients. Also, an exploratory analysis was performed to assess the influence of the T-786C endothelial NO synthase polymorphism on those responses. Methods: Subjects ( n = 26) underwent a 6-month clinical screening for RHTN diagnosis. Increasing doses of oral sildenafil were given at 30 min intervals (37.5, 50 and 100 mg) while continuous non-invasive hemodynamic measures were assessed. LVDF, flow mediated dilation (FMD), nitrite and cGMP levels were also determined. Results: Mean arterial pressure and total peripheral resistance decreased in all patients (84.17 ± 21.04 to 75 ± 17.21 mmHg; 1149 ± 459.7 to 1037 ± 340 dyn.s/cm −5, respectively). Likewise, sildenafil improved diastolic dysfunction parameters (Left atrial volume: 25 ± 5.8 to 20 ± 4.4; IVRT: 104 ± 19.33 to 88 ± 15.22; E/e’ septal: 9.7 ± 3.8 to 7.9 ± 2.9; E/e’ lateral: 7.7 ± 3.4 to 6.4 ± 3.2). No statistical changes were found in FMD, nitrite and cGMP with PDE5i. Conclusion: Our data suggest PDE5i acutely improves diastolic function and hemodynamic profile in RHTN subjects, despite unchanging endothelial dysfunction.
- Subjects
BRAZIL; ANALYSIS of variance; CHI-squared test; DRUG resistance; ECHOCARDIOGRAPHY; GENES; HEART; HEMODYNAMICS; HYPERTENSION; OXIDOREDUCTASES; POLYMERASE chain reaction; RESEARCH funding; STATISTICS; T-test (Statistics); SILDENAFIL; DATA analysis; PRE-tests &; post-tests; REPEATED measures design; DATA analysis software; DESCRIPTIVE statistics
- Publication
European Journal of Clinical Pharmacology, 2013, Vol 69, Issue 12, p2027
- ISSN
0031-6970
- Publication type
Article
- DOI
10.1007/s00228-013-1571-z